Skip to Content

Tetracosactide

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

H01AA02

CAS registry number (Chemical Abstracts Service)

0016960-16-0

Chemical Formula

C136-H210-N40-O31-S

Molecular Weight

2933

Therapeutic Category

Analogue of adrenocorticotropic hormone (ACTH)

Chemical Name

α¹-²⁴-Corticotropin

Foreign Names

  • Tetracosactidum (Latin)
  • Tetracosactid (German)
  • Tétracosactide (French)
  • Tetracosactida (Spanish)

Generic Names

  • Cosyntropin (OS: USAN)
  • Tetracosactide (OS: BAN, DCIT)
  • Tétracosactide (OS: DCF)
  • Ciba 30920 Ba (IS)
  • Corticotropin tetracosapeptide (IS)
  • Tetracosactrin (IS)
  • Tetracosactid (PH: Ph. Eur. 8)
  • Tetracosactide (PH: BP 2015, Ph. Eur. 8)
  • Tétracosactide (PH: Ph. Eur. 8)
  • Tetracosactidum (PH: Ph. Eur. 8)
  • Tetracosactide Acetate (OS: BANM, JAN)
  • Tetracosactidi hexaacetas (IS)
  • Tetracosactrin Acetate (IS)
  • Cosyntropin zinc hydroxide (IS)
  • Tetracosactrin Zinc Injection (PH: BP 2013)

Brand Names

  • Cortrosyn
    Amphastar, Canada
  • Nuvacthen
    IFET, Greece
  • Synachten
    Novartis, Lebanon
  • Synachten Retard
    Novartis, Lebanon
  • Synacthen
    Novartis, Colombia; Novartis, Turkey; SOBI, Sweden
  • Synacthen Depot
    Alliance, United Kingdom; Defiante, Austria; Novartis, Egypt
  • Synacthen-depot
    Novartis, Turkey
  • Synacthene
    IFET, Greece
  • Synacthène
    Sigma-Tau, France
  • Cortrosyn
    Daiichi Sankyo, Japan; MSD, Thailand
  • Cortrosyn Z
    Daiichi Sankyo, Japan
  • Nuvacthen
    Defiante Farmaceutica S.A., Spain
  • Nuvacthen Depot
    Defiante Farmaceutica S.A., Spain
  • Synachten Depot
    Novartis, Romania
  • Synacthen
    Alliance, United Kingdom; Alliance, Malta; CD Pharma, Denmark; Defiante, Austria; Defiante, Italy; Defiante, Netherlands; Mallinckrodt, Switzerland; MPCA, Belgium; Novartis, Argentina; Novartis, New Zealand; Novartis Pharmaceuticals, Australia; Sigma-tau, Germany; Swedish Orphan Biovitrum Ltd., Ireland
  • Synacthen Depot
    Alliance, United Kingdom; Defiante, Portugal; Mallinckrodt, Switzerland; Novartis, New Zealand; Novartis, Oman; Novartis, South Africa; Nycomed, Israel; Sigma-tau, Germany; Novartis, Chile; Novartis Pharmaceuticals, Australia; Novartis Pharmaceuticals, Canada; SOBI, Sweden

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

(web2)